Farmacy

Mar 20 2018

Canadian Pharmacy Online to Usa, buy pharmaceuticals online.#Buy #pharmaceuticals #online

buy pharmaceuticals online How to Get a Good Deal on Your Health Insurance Without Getting Ripped-Off (Twelve Steps to Affordable Health Insurance for You or Your Business) Written by a consumer and small business owner looking to purchase health insurance for his family, this health insurance book contains everything you need to know to buy health insurance wisely, including plenty of resources with tips and advice from nationally recognized health insurance and financial professionals. Whether you need health insurance for yourself, family, or small business this easy to read guide can: Save hundreds of dollars a month Get the right …

Jan 7 2018

UCB to buy Schwarz Pharma for $5 #biotech #company

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …

Jan 7 2018

Actavis to Buy Forest Laboratories for $25 Billion #penn #pharma

#forest pharma # Actavis to Buy Forest Laboratories for $25 Billion Actavis Plc, the world’s second-largest generic-drug maker by market value, agreed to buy Forest Laboratories Inc. for about $25 billion in a deal that will transform it into a developer of brand-name drugs. The deal is a win for billionaire investor Carl Icahn, Forest’s second-largest holder who gained seats on the company’s board in 2012 and 2013, and pushed for a sale. Forest investors will get cash and stock valued at $89.48 a share, based on the Feb. 14 closing price, the companies said today in a statement. The …

Jan 7 2018

Teva to buy Barr Pharma for more than $7b #hra #pharma

#barr pharma #from the September 2008 issue Teva to buy Barr Pharma for more than $7b. Teva Pharmaceutical confirmed its purchase of rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva’s dominance as the world’s largest generic drugmaker. The deal continues consolidation of the generic-drug sector, driven by growth prospects as governments and other payers turn to the lower-priced medications and by the impending expiration of brand-name drug patents worth billions of dollars a year. Israel-based Teva Pharmaceutical Industries Ltd. said acquiring Montvale, N.J.-based Barr Pharmaceuticals Inc. the world’s No. 4 generic drug …

Jan 7 2018

Sun Pharma to buy Dusa for $230 million #schwarz #pharma

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …

Jan 7 2018

Amgen to Buy Onyx for $10 #pharma #headhunters

#onyx pharma # Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Amgen will pay $125 a share for Onyx’s outstanding stock, the companies said in a statement yesterday. Net of estimated Onyx cash, the deal is worth $9.7 billion. Onyx’s Kyprolis, approved last year for a rare blood cancer, may spur more than $3 billion in revenue by 2021, according to analyst estimates compiled by Bloomberg. …

Dec 25 2017

Pharmacom Labs Worldwide Official Distributor since 2008 – Buy Here #esai #pharma

#pharma.com # PULSE Trenbolone for the Very First Steroid Cycle Q: Your articles have two pieces of advice that are totally contrary to recommendations I read on boards everywhere. One, even for a guy s very first cycle you seem to like choosing trenbolone. Everywhere else, the vets shoot that down when anyone suggests that s what they want to do for a first cycle. You also write cycles up around a gram per week for first cycles. Same thing. Are those old recommendations which you ve since changed, or is there a reason behind them? A: I still often …

Dec 22 2017

3 High-Dividend Pharmaceutical Stocks to Buy #pharmaceutical #contract #manufacturer

#pharma stocks # 3 High-Dividend Pharmaceutical Stocks to Buy NEW YORK (TheStreet ) — With Eli Lilly Co. (LLY ) experimenting with a new drug for Alzheimer’s disease, we decided to check Quant Ratings for pharmaceutical stocks to buy. The companies we chose also pay high dividends. Eli Lilly taking a risk on this new drug is nothing new to the industry. The sector is full of risks: Drugs in development might flop; the FDA might not approve them, and even if they are approved, there’s a chance those drugs won’t sell. That said, there are benefits from investing in …

Dec 9 2017

Dublin-based Actavis to buy Forest Labs for $25 billion #pharma #sales #jobs

#forest pharma # Dublin-based Actavis to buy Forest Labs for $25 billion Actavis. the world’s second-largest generic-drug maker by market value, is to buy Forest Laboratories in a cash and stock deal valued at about $25 billion. Actavis will pay the equivalent of $89.48 per share, representing a premium of 25 per cent to Forest’s Friday close. The offer comprises $26.04 in cash and 0.3306 Actavis shares for every Forest share. Forest had a market value of $19.3 billion at the close of trading last Friday. Dublin-headquartered Actavis was the most active buyer of drug companies over the past three …

Dec 8 2017

UCB to buy Schwarz Pharma for $5 #leading #pharmaceutical #companies #2013

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …